Drug Company Settles

JEFFERSON CITY (AP) — Missouri’s attorney general says the state will receive $1.5 million as part of a settlement by a pharmaceutical company with more than three dozen states.

AstraZeneca was accused of marketing its psychiatric drug Seroquel for unapproved uses, including treatment of insomnia and Alzheimer’s disease. The drug is approved to treat schizophrenia, bipolar disorder and depression.

AstraZeneca has denied the allegation but says it agreed to the $68.5 million settlement with 37 states to move forward with its business.

Missouri Attorney General Chris Koster says the settlement ends a three-year investigation. He says the monetary settlement will make other pharmaceutical companies think twice about promoting drugs for unapproved uses.

Copyright Associated Press

  • Danny Haszard

    Zyprexa and Seroquel same saga

    The use of powerful antipsychotic drugs has increased in children as young as three years old. Weight gain, increases in triglyceride levels and associated risks for diabetes and cardiovascular disease.
    The average weight gain (adults) over the 12 week study period was the highest for Zyprexa—17 pounds. You’d be hard pressed to gain that kind of weight sport-eating your way through the holidays.
    One in 145 adults died in clinical trials of those taking the antipsychotic drugs Zyprexa. This is Lilly’s # 1 product over $ 4 billion year sales,moreover Lilly also make billions on drugs that treat the diabetes often that has been caused by the zyprexa!

    Daniel Haszard Zyprexa victim activist and patient who got diabetes from it. http://www.zyprexa-victims.com

blog comments powered by Disqus
Listen Now
Thanksgiving Guide
Make Your Picks!

Listen Live